Search | SPORTIVO Network

rishika_2003 added blog Health
2026-04-20 09:57:51

Global Alfuzosin Market to Reach USD 946.2 Million by 2032 Driven by Rising BPH Prevalence
According to a new report from Intel Market Research, the global Alfuzosin market was valued at USD 693.2 million in 2024 and is projected to reach USD 946.2 million by 2032, growing at a steady CAGR of 4% during the forecast period (2025–2032). This growth trajectory reflects sustained demand for effective therapeutics treating benign prostatic hyperplasia (BPH) and associated lower...

0 Comments 0 Shares 554 Views 0 Reviews

Please log in to like, share and comment!
rohit001 added blog Other
2026-06-26 05:22:28

Microvascular Angiopathy Treatment Market Advances with Expanding Research in Targeted Therapies and Improved Diagnostic Approaches
According to the latest report published by Data Bridge Market Research, the Microvascular Angiopathy Treatment Market The global microvascular angiopathy treatment market size was valued at USD 3.52 billion in 2024 and is expected to reach USD 5.36 billion by 2032, at a CAGR of 5.40% during the forecast period This Microvascular Angiopathy Treatment Market research report is...

0 Comments 0 Shares 283 Views 0 Reviews

Please log in to like, share and comment!
rohit001 added blog Other
2026-06-26 07:47:21

Montelukast Sodium Market Strengthens with Expanding Generic Manufacturing and Sustained Demand Across Global Pharmaceutical Supply Chains
According to the latest report published by Data Bridge Market Research, the Montelukast Sodium Market The global montelukast sodium market size was valued at USD 522.06 million in 2024 and is expected to reach USD 1,653.39 million by 2032, at a CAGR of 15.50% during the forecast period The Montelukast Sodium Marketdocument identifies and analyses the emerging trends along with major drivers,...

0 Comments 0 Shares 290 Views 0 Reviews

Please log in to like, share and comment!
rishika_2003 added blog Health
2026-04-20 11:36:45

SSRIs Market Expands with Advancements in Antidepressant Therapies and Global Healthcare Access
According to a new report from Intel Market Research, the global Selective Serotonin Reuptake Inhibitors (SSRIs) market was valued at USD 4.69 billion in 2024 and is projected to reach USD 6.05 billion by 2034, growing at a CAGR of 3.8% during the forecast period (2025-2034). This growth is driven by rising mental health awareness, expanded insurance coverage for psychiatric treatments, and the...

0 Comments 0 Shares 711 Views 0 Reviews

Please log in to like, share and comment!